Announcements Trials
Browse Landscape

Status

Completed 3Unknown 1

Sponsor Class

OTHER 16INDUSTRY 4NIH 2

Study Type

Observational 4

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Neoplasms 3216Carcinoma, Non-Small-Cell Lung 2729Breast Neoplasms 2551Colorectal Neoplasms 1463Prostatic Neoplasms 1307Neoplasm Metastasis 1301Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 945Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 833Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 473Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 436Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Dysplastic Nevus Syndrome × Clear all
NCT04368247 2025-08-07

Skin Fluorescent Imaging (SFI) System in Patients With Nevi

Orlucent, Inc

Completed
300 enrolled

Carcinoma in Situ, Dysplastic Nevus Syndrome, Nevus

NCT06246903 2024-02-07

INTER-PATHOLOGIST READER STUDY

Orlucent, Inc

Unknown
500 enrolled

Dysplastic Nevus Syndrome

NCT03535077 2024-01-10

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

Orlucent, Inc

Completed
186 enrolled
Dermatologic

Dysplastic Nevus Syndrome, Melanoma, Nevus

NCT03693378 2022-03-31

A Study of IMMrayâ„¢ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Immunovia, Inc.

Completed
1,349 enrolled
Gastrointestinal

Pancreatic carcinoma, familial, Dysplastic Nevus Syndrome, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡